Your browser doesn't support javascript.
loading
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.
Schliemann, Christoph; Gerwing, Mirjam; Heinzow, Hauke; Harrach, Saliha; Schwöppe, Christian; Wildgruber, Moritz; Hansmeier, Anna A; Angenendt, Linus; Berdel, Andrew F; Stalmann, Ursula; Berning, Björna; Kratz-Albers, Karsten; Middelberg-Bisping, Kristina; Wiebe, Stefanie; Albring, Jörn; Wilms, Christian; Hartmann, Wolfgang; Wardelmann, Eva; Krähling, Tobias; Heindel, Walter; Gerss, Joachim; Bormann, Eike; Schmidt, Hartmut; Lenz, Georg; Kessler, Torsten; Mesters, Rolf M; Berdel, Wolfgang E.
Afiliação
  • Schliemann C; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Gerwing M; Institute for Clinical Radiology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Heinzow H; Department of Medicine B, Gastroenterology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Harrach S; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Schwöppe C; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Wildgruber M; Institute for Clinical Radiology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Hansmeier AA; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Angenendt L; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Berdel AF; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Stalmann U; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Berning B; Oncology Practice, D-48431 Rheine, Germany.
  • Kratz-Albers K; Group Practice Hematology Oncology, D-48149 Muenster, Germany.
  • Middelberg-Bisping K; Department of Medicine, Marienhospital Osnabrück, D-49074 Osnabrück, Germany.
  • Wiebe S; Department of Hematology Oncology, St. Franziskus Hospital, D-48145 Muenster, Germany.
  • Albring J; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Wilms C; Department of Medicine B, Gastroenterology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Hartmann W; Gerhard-Domagk-Institute for Pathology, University of Muenster, D-48149 Muenster, Germany.
  • Wardelmann E; Gerhard-Domagk-Institute for Pathology, University of Muenster, D-48149 Muenster, Germany.
  • Krähling T; Institute for Clinical Radiology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Heindel W; Institute for Clinical Radiology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Gerss J; Institute of Biostatistics and Clinical Research, University of Muenster, D-48149 Muenster, Germany.
  • Bormann E; Institute of Biostatistics and Clinical Research, University of Muenster, D-48149 Muenster, Germany.
  • Schmidt H; Department of Medicine B, Gastroenterology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Lenz G; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Kessler T; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Mesters RM; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
  • Berdel WE; Department of Medicine A, Hematology, Oncology, University Hospital Muenster, D-48149 Muenster, Germany.
Cancers (Basel) ; 12(6)2020 Jun 07.
Article em En | MEDLINE | ID: mdl-32517329

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article